EP1670518A4

Rna interference for the treatment of gain-of-function disorders

Abstract

This record has no abstract on file.

EP1670518A4, drawing sheet 1 — Sheet 1 of 38

Term

Term ended

Projected expiry passed 13 September 2024, 2 years ago.

38 sheets

Sheet 1
Sheet 2
Sheet 3
Sheet 4
Sheet 5
Sheet 6
Sheet 7
Sheet 8
Sheet 9
Sheet 10
Sheet 11
Sheet 12
Sheet 13
Sheet 14
Sheet 15
Sheet 16
Sheet 17
Sheet 18
Sheet 19
Sheet 20
Sheet 21
Sheet 22
Sheet 23
Sheet 24
Sheet 25
Sheet 26
Sheet 27
Sheet 28
Sheet 29
Sheet 30
Sheet 31
Sheet 32
Sheet 33
Sheet 34
Sheet 35
Sheet 36
Sheet 37
Sheet 38

Every citation, both waysCites: the store holds 6 of 7

Citations
Document	Relation	Office	Category	Cited during	Relevant claims
WO03013437A2	Cites	World Intellectual Property Organization (WIPO)	Y	Search report	1-11
WO2004042027A2	Cites	World Intellectual Property Organization (WIPO)	PX	Search report	1-11
WO2004047872A2	Cites	World Intellectual Property Organization (WIPO)	PX	Search report	1-11
WO2004047872A	Cites	World Intellectual Property Organization (WIPO)	–	–	–
WO2004042027A	Cites	World Intellectual Property Organization (WIPO)	–	–	–
WO03013437A	Cites	World Intellectual Property Organization (WIPO)	–	–	–
DING H ET AL: "Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis", AGING CELL, BLACKWELL PUBLISHING,, GB, vol. 2, 2003, pages 209 - 217, XP002389534, ISSN: 1474-9718	Non-patent	–	–	Search report	–
CAPLEN N J ET AL: "Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference", HUMAN MOLECULAR GENETICS, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 11, no. 2, 15 January 2002 (2002-01-15), pages 175 - 184, XP002380705, ISSN: 0964-6906	Non-patent	–	–	Search report	–
NELLEMANN C ET AL: "Inhibition of Huntingtin synthesis by antisense oligonuleotides", MOLECULAR AND CELLULAR NEUROSCIENCES, SAN DIEGO, US, vol. 16, October 2000 (2000-10-01), pages 313 - 323, XP002960853, ISSN: 1044-7431	Non-patent	–	–	Search report	–
GOTO J ET AL: "SUPPRESSION OF HUNTINGTIN GENE EXPRESSION BY SIRNA: A POSSIBLE THERAPEUTIC TOOL FOR HUNTINGTON'S DISEASE", NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, PHILADELPHIA, US, vol. 60, no. 5, SUPPL 1, 11 March 2003 (2003-03-11), pages A286, XP009029181, ISSN: 0028-3878	Non-patent	–	–	Search report	–
SCHWARZ DIANNE S ET AL: "Designing siRNA that distinguish between genes that differ by a single nucleotide", PLOS GENETICS, vol. 2, no. 9, September 2006 (2006-09-01), pages 1307 - 1318, XP002434423, ISSN: 1553-7390(print) 1553-7404(ele	Non-patent	–	–	Search report	–
MACDONALD M E ET AL: "A NOVEL GENE CONTAINING A TRINUCLEOTIDE REPEAT THAT IS EXPANDED AND UNSTABLE ON HUNTINGTON'S DISEASE CHROMOSOMES", CELL, CELL PRESS, CAMBRIDGE, NA, US, vol. 72, 26 March 1993 (1993-03-26), pages 971 - 983, XP000199501, ISSN: 0092-8674	Non-patent	–	–	Search report	–
See also references of WO 2005027980A1	Non-patent	–	–	Search report	–

33 members in 7 offices

This recordMember, by publication datePriority claim

Priority claims9

Priority claims
Document	Office	Kind	Date
502678P	United States of America	–	2003-09-12
50267803	United States of America	P	2003-09-12
50267803	United States of America	P	2003-09-12
2004029968	United States of America	W	2004-09-13
2004029968	United States of America	W	2004-09-13
502678P	–	–	–
US20030502678P	–	–	–
US2004029968	–	–	–
WO2004US29968	–	–	–

Members33

Family members, oldest first
Document	Office	Kind
CA2579638A1	Canada	A1	2005-03-31
WO2005027980A1	World Intellectual Property Organization (WIPO)	A1	2005-03-31
EP1670518A1	European Patent Office (EPO)	A1	2006-06-21
EP1670518A4This record	European Patent Office (EPO)	A4	2007-10-10
CA2662704A1	Canada	A1	2008-01-10
WO2008005562A2	World Intellectual Property Organization (WIPO)	A2	2008-01-10
WO2008005562A3	World Intellectual Property Organization (WIPO)	A3	2008-11-20
EP2046993A2	European Patent Office (EPO)	A2	2009-04-15
US2009118206A1	United States of America	A1	2009-05-07
US2009186410A1	United States of America	A1	2009-07-23
EP2046993A4	European Patent Office (EPO)	A4	2010-11-17
US7947658B2	United States of America	B2	2011-05-24
US2011172291A1	United States of America	A1	2011-07-14
US8680063B2	United States of America	B2	2014-03-25
EP1670518B1	European Patent Office (EPO)	B1	2014-05-21
ES2485848T3	Spain	T3	2014-08-14
US2014370597A1	United States of America	A1	2014-12-18
EP2821085A2	European Patent Office (EPO)	A2	2015-01-07
EP2821085A3	European Patent Office (EPO)	A3	2015-04-22
CA2579638C	Canada	C	2016-04-19
US9434943B2	United States of America	B2	2016-09-06
US2017051283A1	United States of America	A1	2017-02-23
US10344277B2	United States of America	B2	2019-07-09
US2020024599A1	United States of America	A1	2020-01-23
EP2821085B1	European Patent Office (EPO)	B1	2020-04-29
PT2821085T	Portugal	T	2020-07-28
DK2821085T3	Denmark	T3	2020-08-03
EP3760234A2	European Patent Office (EPO)	A2	2021-01-06
ES2808561T3	Spain	T3	2021-03-01
EP3760234A3	European Patent Office (EPO)	A3	2021-04-07
US11299734B2	United States of America	B2	2022-04-12
EP3760234B1	European Patent Office (EPO)	B1	2023-11-01
ES2969371T3	Spain	T3	2024-05-17

79 legal events, as 11 offices reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code	Office
2024-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-10-29	Ep patent has lapsedLapsedEUG	EUG	SE
2024-10-21	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-10-14	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-10-02	Patent expired after termination of 20 yearsExpiredPE20	PE20	GB
2024-09-27	Announcement of lapse in spainLapsedFD2A	FD2A	ES
2024-09-13	Expiry of rightR071	R071	DE
2024-01-22	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-11-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-11-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-11-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-10-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-10-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-07-12	Opt-out of the competence of the unified patent court (upc) registeredP01	P01	EP
2021-01-12	Change of representativeR082	R082	DE
2021-01-12	Change of representativeR082	R082	DE
2018-09-25	Fee paymentPLFP	PLFP	FR
2017-09-25	Fee paymentPLFP	PLFP	FR
2016-09-26	Fee paymentPLFP	PLFP	FR
2016-07-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2016-07-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2016-06-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2016-05-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-06-17	Patent lapsedLapsedMM4A	MM4A	IE
2015-06-03	No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097	R097	DE
2015-04-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-04-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-04-30	Patent ceasedCeasedPL	PL	CH
2015-04-29	No opposition filedOpposition26N	26N	EP
2015-03-27	No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE	PLBE	EP
2015-03-27	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA	STAA	EP
2015-02-27	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-02-24	No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097	R097	DE
2015-01-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-01-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-01-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-01-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-01-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-01-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2014-12-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2014-11-28	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2014-11-28	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2014-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2014-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2014-10-27	Invalidation of extension of european patentsMG9D	MG9D	LT
2014-10-15	Deletion acc. to par. 5 (withdrawal of the translation of the ep patent)MK05	MK05	AT
2014-10-15	Discontinued in the netherlands as no translation has been filedVDEP	VDEP	NL
2014-08-26	Translation of granted ep patentGrantedTRGR	TRGR	SE
2014-08-14	Definitive protectionFG2A	FG2A	ES
2014-07-03	Dpma publication of mentioned ep patent grantGrantedR096	R096	DE
2014-06-18	European patents granted designating irelandGrantedFG4D	FG4D	IE
2014-06-15	Reference to at number (ep patent validated in austria)REF	REF	AT
2014-05-30	European patent takes effect as a national patent in ch/liEP	EP	CH
2014-05-21	Designated contracting statesAK	AK	EP
2014-05-21	Request for extension of the european patentAX	AX	EP
2014-05-21	European patent grantedGrantedFG4D	FG4D	GB
2014-04-18	(expected) grantORIGINAL CODE: 0009210GRAA	GRAA	EP
2014-04-17	Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS	GRAS	EP
2014-01-01	Intention to grant announcedINTG	INTG	EP
2013-12-04	Intention to grant announcedINTG	INTG	EP
2013-12-04	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2013-12-04	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2013-12-03	Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP	GRAP	EP
2013-11-26	Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deletedORIGINAL CODE: EPIDOSDIGR1GRAJ	GRAJ	EP
2013-11-11	Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP	GRAP	EP
2008-07-02	First examination report despatched17Q	17Q	EP
2007-10-10	Supplementary search report drawn up and despatchedA4	A4	EP
2007-06-27	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2007-06-27	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2007-06-27	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2006-06-21	Request for examination filed17P	17P	EP
2006-06-21	Designated contracting statesAK	AK	EP
2006-06-21	Request for extension of the european patentAX	AX	EP
2006-05-19	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI	EP

Rna interference for the treatment of gain-of-function disorders

Abstract

Term

Priority claims9

Members33

Over the term

Events

Numbers

Titles3

Classification

Designated states2